Top

Intensive Care Medicine

Published in:

01-02-2009 | Original

Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study

Authors: Lukas Schwake, Ines Wollenschläger, Wolfgang Stremmel, Jens Encke

Published in: Intensive Care Medicine | Issue 2/2009

Abstract

Objective

The aim of the present study was (1) to determine the prevalence of intensive care unit (ICU) admissions due to an adverse drug reaction (ADR), and (2) to compare affected patients with patients admitted to the ICU for the treatment of deliberate self-poisoning using medical drugs.

Design

Prospective observational cohort study.

Setting

Fourteen bed medical ICU including an integrated intermediate care (IMC) section at a tertiary referral center.

Patients

A total of 1,554 patients admitted on 1 January 2003 to 31 December 2003.

Results

Ninety-nine patients were admitted to the ICU with a diagnosis of ADR (6.4% of all admissions), 269 admissions (17.3%) were caused by deliberate self-poisoning. Patients admitted for treatment of ADR had a significantly higher age, a longer treatment duration in the ICU, a higher SAPS II score, and a higher 6-month mortality than those with deliberate self-poisoning. Most patients (71.7%) suffering from ADR required advanced supportive care in the ICU while the majority of patients (90.7%) with deliberate self-poisoning could be sufficiently treated in the IMC area. All diagnostic and therapeutic procedures in the ICU except mechanical ventilation were significantly more often performed in patients with ADR.

Conclusions

This study provides further evidence that ADR is a frequent cause of admission to medical ICUs resulting in a considerable use of ICU capacities. In the present setting patients with ADR required longer and more intense medical treatment in the ICU than those with deliberate self-poisoning.

Kaufmann DW, Shapiro S (2000) Epidemiological assessment of drug-induced disease. Lancet 356:1339–1343CrossRef

Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis and management. Lancet 356:1255–1259PubMedCrossRef

Lazarou J, Pomeranz B, Corey P (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205PubMedCrossRef

Kelly WN (2001) Can the frequency and risks of fatal adverse drug events be determined? Pharmacotherapy 21:521–527PubMedCrossRef

Bond CA, Raehl CL (2006) Adverse drug reactions in United States Hospitals. Pharmacotherapy 26:601–608PubMedCrossRef

Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 329:15–19PubMedCrossRef

Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Tröger M, Azaz-Livshits T, Levy M, Brune K, Hahn EG (2004) Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 255:653–663PubMedCrossRef

Trunet P, Le Gall JR, Lhoste F, Regnier B, Saillard Y, Carlet J, Rapin M (1980) The role of iatrogenic disease in admissions to intensive care. JAMA 244:2617–2620PubMedCrossRef

Farina ML, Tognoni G, Procaccio F (1987) Epidemiology of adverse drug reactions in intensive care unit. Arch Intern Med 159:71–78

10.

Darchy B, Le Miere E, Figuredo B, Bavoux E, Domart Y (1999) Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 159:71–78PubMedCrossRef

11.

Lehmann LS, Puopolo AL, Shaykevich S, Brennan TA (2005) Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions. Am J Med 118:409–413PubMedCrossRef

12.

Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salame G, Etienne G, Robinson P, Gruson D, Hilbert G, Gabinski C, Begaud B, Molimard M (2007) Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Int Care Med 33:2150–2157CrossRef

13.

Le Gall JR, Lemeshow S, Saulnier F (1993) A new acute simplified score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMedCrossRef

14.

Somers A, Petrovic M, Robays H, Bogaert M (2003) Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 58:707–714PubMed

15.

Ramesh M, Pandit J, Parthasarathi G (2003) Adverse drug reactions in a Southern Indian hospital—their severity and cost involvement. Pharmacol Drug Safe 12:687–692CrossRef

16.

Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW (2003) Adverse drug reactions in ambulatory care. N Engl J Med 348:1556–1564PubMedCrossRef

17.

Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: a clinicians guide to terminology, documentation, and reporting. Ann Intern Med 140:795–801PubMed

18.

Nebeker JR, Hoffmann JM, Weir CR, Bennett CL, Hurdle JF (2005) High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 165:1111–1116PubMedCrossRef

19.

Lindquist M, Edwards IR (2001) The WHO programme for International Drug Monitoring, its database, and the technical support of the Upssala Monitoring Center. J Rheumatol 28:1180–1187PubMed

20.

Santos WJQS, Zanetta DMT, Pires AC, Lobol SMA, Lima EQL, Burdmann EA (2006) Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit— a homogeneous population? Crit Care 10:R68 (10.1186/cc4904)

21.

Kapur N, Cooper J, King-Hele S, Webb R, Lawlor M, Rodway C, Appleby L (2006) The repetition of suicidal behaviour: a multicenter cohort study. J Clin Psychiatry 67:1599–1609PubMedCrossRef

22.

Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N (1990) Drug related admissions to a cardiology department; frequency and avoidability. J Intern Med 228:379–384PubMedCrossRef

23.

Hallas J, Gram LF, Grodum E, Damsbo N, Brøsen K, Haghfelt T, Harvald B, Beck-Nielsen J, Worm J, Jensen KB (1992) Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 33:61–68PubMed

24.

Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58:285–291PubMedCrossRef

25.

Cullen DJ, Sweitzer BJ, Bates DW, Burdick EMS, Edmondson A, Leape LL (1997) Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care unit. Crit Care Med 25:1289–1297PubMedCrossRef

26.

Kane-Gill SL, Devlin JW (2006) Adverse drug event reporting in intensive care units: a survey of current practices. Ann Pharmacother 40:1267–1273PubMedCrossRef

27.

Hawton K, Fagg J, Simkin S, Bale E, Bond A (1997) Trends in deliberate self-harm in Oxford, 1985–1995. Br J Psychiatr 171:556–560CrossRef

28.

Schaper A, Renneberg B, Desel H, Langer C (2006) Intoxication-related fatalities in northern Germany. Eur J Intern Med 17:474–478PubMedCrossRef

29.

O’Loughlin S, Sherwood J (2005) A 20-year review of trends in deliberate self-harm in Kidderminster, 1981–2000. Soc Psychiatry Psychiatr Epidemiol 40:446–453PubMedCrossRef

30.

Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW (1995) Self-poisoning in Newcastle, 1987–1992. Med J Aust 162:190–193PubMed

31.

Whyte IM, Dawson AH, Buckley NA, Carter GL, Levey CM (1997) A model for the management of self-poisoning. Med J Aust 167:142–146PubMed

32.

Michel K (2000) Methods used for parasuicide: results of the WHO/EURO Multicentre Study on Parasuicide. Soc Psychiatry Psychiatr Epidemiol 35:156–163PubMedCrossRef

33.

Carter GL, Clover K, Whyte IM, Dawson AH, D’Este C (2005) Postcards from the Edge project: randomised controlled trial of an intervention using postcards to reduce repetition of hospital treated deliberate self poisoning. BMJ. 10.1136/bmj.38579.455266.E0

34.

Riedl MA, Casillas AM (2003) Adverse drug reactions: types and treatment options. Am Fam Physician 68:1781–1790PubMed

35.

Johnstone DM, Kirking DM, Vinson BE (1995) Comparison of adverse drug reactions detected by pharmacy and medical records departments. Am J Health Syst Pharm 52:297–301PubMed

36.

Kapur N, Cooper J, Hiroeh U, May C, Appleby L, House A (2004) Emergency department management and outcome for self-poisoning: a cohort study. Gen Hosp Psychiatry 26:36–41PubMedCrossRef

37.

Kelly CB, Weir J, Rafferty T, Galloway R (2000) Deliberate self-poisoning presenting at a rural hospital in Northern Ireland 1976–1996: relationship to prescribing. Eur Psychiatry 15:348–353PubMedCrossRef

38.

Owens D, Horrocks J, House A (2002) Fatal and non-fatal repetition of self-harm: systematic review. Br J Psychiatr 181:193–199CrossRef

39.

Schneeweiss SG, Goettler M, Hasford J (1997) Adverse drug events in hospitalized patients. JAMA 277:1352–1353PubMedCrossRef

40.

Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, Molimard M, Haramburu F (2005) Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 61:169–173PubMedCrossRef

Title: Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study
Authors: Lukas Schwake
Ines Wollenschläger
Wolfgang Stremmel
Jens Encke
Publication date: 01-02-2009
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 2/2009
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-008-1250-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study

Abstract

Objective

Design

Setting

Patients

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Setting

Patients

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2009

Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands

Time dependent decrease in blood glucose levels after sampling potentially affects intensive insulin therapy in the intensive care unit

Chronic sleep disorders in survivors of the acute respiratory distress syndrome

The strong ion gap and outcome after cardiac arrest in patients treated with therapeutic hypothermia: a retrospective study

Effect of SOD-1 over-expression on myocardial function during resuscitated murine septic shock

Sleep and non-invasive ventilation in patients with chronic respiratory insufficiency